As per the research conducted by KD Market research, the report titled “ Rapid Tests Market ” provides current as well as future analysis of the market by evaluating the major applications, advantages, trends, and challenges. The report dives deeper to produce useful insights into Rapid Tests Market such as major global regions and key competitors and strategies that can be used for the entry-level player too.
Request for sample@ https://www.kdmarketresearch.com/sample/3186
The global rapid tests market generated $21,455 million in 2016, and is projected to reach $39,103 million by 2023, growing at a CAGR of 8.9% from 2017 to 2023. Rapid tests are diagnostic assays designed for use where preliminary screening tests need to be conducted. These tests are easy, quick, and provide specific results; hence, are used in settings with limited resources. Rapid tests are incorporated in diagnosis of different diseases and health conditions such as HIV, influenza, malaria, cancer, pregnancy & fertility, and others.
The rapid tests market is expected to grow at a significant rate during the forecast period, owing to increase in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and need for low cost as well as accurate diagnostic testing. In addition, growth in personalized care and increased promotional activities by manufacturers encourage the usage rapid tests, which further facilitate the growth of the market. However, stringent government regulations for the approval of rapid tests and recall of several products due to false results are expected to impede the market growth.
The global rapid tests market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into over-the-counter (OTC) rapid test product and professional rapid test product. By application, the market is classified into infectious disease, cardiology, oncology, pregnancy & fertility, toxicology, glucose monitoring, and others. According to end user, it is segmented as hospital & clinic, diagnostic laboratory, home care, and others. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product
By Application
Infectious Disease
HPV
Hepatitis
Influenza
Malaria
HIV
Others
Cardiology
Oncology
Pregnancy & Fertility
Toxicology
Glucose Monitoring
Others
By End User
Hospital & Clinic
Diagnostic Laboratory
Home Care
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Akers Biosciences, Inc.
Alere Inc. (Abbott Laboratories)
Becton, Dickinson and Company
Bio-rad Laboratories, Inc.
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Abingdon Health
ARKRAY, Inc.
Biocom Diagnostics
Biomerica, Inc.
Demeditec Diagnostics GmbH
Epitope Diagnostics Inc.
NanoRepro AG.
Randox Laboratories Ltd.
Browse full report with toc@ https://www.kdmarketresearch.com/report/3186/rapid-tests-market-amr
Table of content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Benefits of rapid tests over laboratory testing
3.4.1.2. Increase in initiatives of government and nonprofit organizations towards health awareness
3.4.1.3. Increase in healthcare expenditure worldwide
3.4.2. Restraint
3.4.2.1. Inadequate reimbursement policies for rapid test diagnostics
3.4.3. Opportunities
3.4.3.1. Growth opportunities in the emerging markets
3.4.3.2. Increase in prevalence of various chronic and infectious diseases across the world
3.4.4. Impact analysis
CHAPTER 4: RAPID TESTS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Over-the-counter (OTC) rapid test products
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Professional rapid test products
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: RAPID TESTS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Infectious disease
5.2.1. Market size and forecast, by type
5.2.1.1. HPV rapid tests
5.2.1.1.1. Market size and forecast
5.2.1.2. Hepatitis rapid tests
5.2.1.2.1. Market size and forecast
5.2.1.3. Influenza rapid tests
5.2.1.3.1. Market size and forecast
5.2.1.4. Malaria rapid tests
5.2.1.4.1. Market size and forecast
5.2.1.5. HIV rapid tests
5.2.1.5.1. Market size and forecast
5.2.1.6. Other infectious disease rapid tests
5.2.1.6.1. Market size and forecast
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Cardiology
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Oncology
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Pregnancy & fertility
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Toxicology
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
5.7. Glucose monitoring
5.7.1. Market size and forecast
5.7.2. Market analysis, by country
5.8. Other applications
5.8.1. Market size and forecast
5.8.2. Market analysis, by country
CHAPTER 6: RAPID TESTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Diagnostic laboratories
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Home care
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Others
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: RAPID TESTS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. rapid tests market, by product
7.2.2.1.2. U.S. rapid tests market, by application
7.2.2.1.3. U.S. rapid tests market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada rapid tests market, by product
7.2.2.2.2. Canada rapid tests market, by application
7.2.2.2.3. Canada rapid tests market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico rapid tests market, by product
7.2.2.3.2. Mexico rapid tests market, by application
7.2.2.3.3. Mexico rapid tests market, by end user
7.2.3. North America rapid tests market, by product
7.2.4. North America rapid tests market, application
7.2.5. North America rapid tests market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany rapid tests market, by product
7.3.2.1.2. Germany rapid tests market, by application
7.3.2.1.3. Germany rapid tests market, by end user
7.3.2.2. France
7.3.2.2.1. France rapid tests market, by product
7.3.2.2.2. France rapid tests market, by application
7.3.2.2.3. France rapid tests market, by end user
7.3.2.3. UK
7.3.2.3.1. UK rapid tests market, by product
7.3.2.3.2. UK rapid tests market, by application
7.3.2.3.3. UK rapid tests market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy rapid tests market, by product
7.3.2.4.2. Italy rapid tests market, by application
7.3.2.4.3. Italy rapid tests market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain rapid tests market, by product
7.3.2.5.2. Spain rapid tests market, by application
7.3.2.5.3. Spain rapid tests market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe rapid tests market, by product
7.3.2.6.2. Rest of Europe rapid tests market, by application
7.3.2.6.3. Rest of Europe rapid tests market, by end user
7.3.3. Europe rapid tests market, by product
7.3.4. Europe rapid tests market, application
7.3.5. Europe rapid tests market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan rapid tests market, by product
7.4.2.1.2. Japan rapid tests market, by application
7.4.2.1.3. Japan rapid tests market, by end user
7.4.2.2. China
7.4.2.2.1. China rapid tests market, by product
7.4.2.2.2. China rapid tests market, by application
7.4.2.2.3. China rapid tests market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia rapid tests market, by product
7.4.2.3.2. Australia rapid tests market, by application
7.4.2.3.3. Australia rapid tests market, by end user
7.4.2.4. India
7.4.2.4.1. India rapid tests market, by product
7.4.2.4.2. India rapid tests market, by application
7.4.2.4.3. India rapid tests market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea rapid tests market, by product
7.4.2.5.2. South Korea rapid tests market, by application
7.4.2.5.3. South Korea rapid tests market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific rapid tests market, by product
7.4.2.6.2. Rest of Asia-Pacific rapid tests market, by application
7.4.2.6.3. Rest of Asia-Pacific rapid tests market, by end user
7.4.3. Asia-Pacific rapid tests market, by product
7.4.4. Asia-Pacific rapid tests market, application
7.4.5. Asia-Pacific rapid tests market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil rapid tests market, by product
7.5.2.1.2. Brazil rapid tests market, by application
7.5.2.1.3. Brazil rapid tests market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia rapid tests market, by product
7.5.2.2.2. Saudi Arabia rapid tests market, by application
7.5.2.2.3. Saudi Arabia rapid tests market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa rapid tests market, by product
7.5.2.3.2. South Africa rapid tests market, by application
7.5.2.3.3. South Africa rapid tests market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA rapid tests market, by product
7.5.2.4.2. Rest of LAMEA rapid tests market, by application
7.5.2.4.3. Rest of LAMEA rapid tests market, by end user
7.5.3. LAMEA rapid tests market, by product
7.5.4. LAMEA rapid tests market, application
7.5.5. LAMEA rapid tests market, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Akers Biosciences, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Abbott Laboratories (Alere Inc.)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Becton, Dickinson and Company
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Bio-Rad Laboratories, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Danaher Corporation (Cepheid, Inc.)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Hologic, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Meridian Bioscience, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. OraSure Technologies, Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Quidel Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. F. Hoffmann-La Roche AG (Roche Diagnostics)
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
continue....
Check for discount@ https://www.kdmarketresearch.com/discount/3186
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us - KD Market Research
150 State Street, Albany,
New York, USA 12207
Email id sales@kdmarketresearch.com
Request for sample@ https://www.kdmarketresearch.com/sample/3186
The global rapid tests market generated $21,455 million in 2016, and is projected to reach $39,103 million by 2023, growing at a CAGR of 8.9% from 2017 to 2023. Rapid tests are diagnostic assays designed for use where preliminary screening tests need to be conducted. These tests are easy, quick, and provide specific results; hence, are used in settings with limited resources. Rapid tests are incorporated in diagnosis of different diseases and health conditions such as HIV, influenza, malaria, cancer, pregnancy & fertility, and others.
The rapid tests market is expected to grow at a significant rate during the forecast period, owing to increase in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and need for low cost as well as accurate diagnostic testing. In addition, growth in personalized care and increased promotional activities by manufacturers encourage the usage rapid tests, which further facilitate the growth of the market. However, stringent government regulations for the approval of rapid tests and recall of several products due to false results are expected to impede the market growth.
The global rapid tests market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into over-the-counter (OTC) rapid test product and professional rapid test product. By application, the market is classified into infectious disease, cardiology, oncology, pregnancy & fertility, toxicology, glucose monitoring, and others. According to end user, it is segmented as hospital & clinic, diagnostic laboratory, home care, and others. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product
By Application
Infectious Disease
HPV
Hepatitis
Influenza
Malaria
HIV
Others
Cardiology
Oncology
Pregnancy & Fertility
Toxicology
Glucose Monitoring
Others
By End User
Hospital & Clinic
Diagnostic Laboratory
Home Care
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Akers Biosciences, Inc.
Alere Inc. (Abbott Laboratories)
Becton, Dickinson and Company
Bio-rad Laboratories, Inc.
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Abingdon Health
ARKRAY, Inc.
Biocom Diagnostics
Biomerica, Inc.
Demeditec Diagnostics GmbH
Epitope Diagnostics Inc.
NanoRepro AG.
Randox Laboratories Ltd.
Browse full report with toc@ https://www.kdmarketresearch.com/report/3186/rapid-tests-market-amr
Table of content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Benefits of rapid tests over laboratory testing
3.4.1.2. Increase in initiatives of government and nonprofit organizations towards health awareness
3.4.1.3. Increase in healthcare expenditure worldwide
3.4.2. Restraint
3.4.2.1. Inadequate reimbursement policies for rapid test diagnostics
3.4.3. Opportunities
3.4.3.1. Growth opportunities in the emerging markets
3.4.3.2. Increase in prevalence of various chronic and infectious diseases across the world
3.4.4. Impact analysis
CHAPTER 4: RAPID TESTS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Over-the-counter (OTC) rapid test products
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Professional rapid test products
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: RAPID TESTS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Infectious disease
5.2.1. Market size and forecast, by type
5.2.1.1. HPV rapid tests
5.2.1.1.1. Market size and forecast
5.2.1.2. Hepatitis rapid tests
5.2.1.2.1. Market size and forecast
5.2.1.3. Influenza rapid tests
5.2.1.3.1. Market size and forecast
5.2.1.4. Malaria rapid tests
5.2.1.4.1. Market size and forecast
5.2.1.5. HIV rapid tests
5.2.1.5.1. Market size and forecast
5.2.1.6. Other infectious disease rapid tests
5.2.1.6.1. Market size and forecast
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Cardiology
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Oncology
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Pregnancy & fertility
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Toxicology
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
5.7. Glucose monitoring
5.7.1. Market size and forecast
5.7.2. Market analysis, by country
5.8. Other applications
5.8.1. Market size and forecast
5.8.2. Market analysis, by country
CHAPTER 6: RAPID TESTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Diagnostic laboratories
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Home care
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Others
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: RAPID TESTS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. rapid tests market, by product
7.2.2.1.2. U.S. rapid tests market, by application
7.2.2.1.3. U.S. rapid tests market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada rapid tests market, by product
7.2.2.2.2. Canada rapid tests market, by application
7.2.2.2.3. Canada rapid tests market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico rapid tests market, by product
7.2.2.3.2. Mexico rapid tests market, by application
7.2.2.3.3. Mexico rapid tests market, by end user
7.2.3. North America rapid tests market, by product
7.2.4. North America rapid tests market, application
7.2.5. North America rapid tests market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany rapid tests market, by product
7.3.2.1.2. Germany rapid tests market, by application
7.3.2.1.3. Germany rapid tests market, by end user
7.3.2.2. France
7.3.2.2.1. France rapid tests market, by product
7.3.2.2.2. France rapid tests market, by application
7.3.2.2.3. France rapid tests market, by end user
7.3.2.3. UK
7.3.2.3.1. UK rapid tests market, by product
7.3.2.3.2. UK rapid tests market, by application
7.3.2.3.3. UK rapid tests market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy rapid tests market, by product
7.3.2.4.2. Italy rapid tests market, by application
7.3.2.4.3. Italy rapid tests market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain rapid tests market, by product
7.3.2.5.2. Spain rapid tests market, by application
7.3.2.5.3. Spain rapid tests market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe rapid tests market, by product
7.3.2.6.2. Rest of Europe rapid tests market, by application
7.3.2.6.3. Rest of Europe rapid tests market, by end user
7.3.3. Europe rapid tests market, by product
7.3.4. Europe rapid tests market, application
7.3.5. Europe rapid tests market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan rapid tests market, by product
7.4.2.1.2. Japan rapid tests market, by application
7.4.2.1.3. Japan rapid tests market, by end user
7.4.2.2. China
7.4.2.2.1. China rapid tests market, by product
7.4.2.2.2. China rapid tests market, by application
7.4.2.2.3. China rapid tests market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia rapid tests market, by product
7.4.2.3.2. Australia rapid tests market, by application
7.4.2.3.3. Australia rapid tests market, by end user
7.4.2.4. India
7.4.2.4.1. India rapid tests market, by product
7.4.2.4.2. India rapid tests market, by application
7.4.2.4.3. India rapid tests market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea rapid tests market, by product
7.4.2.5.2. South Korea rapid tests market, by application
7.4.2.5.3. South Korea rapid tests market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific rapid tests market, by product
7.4.2.6.2. Rest of Asia-Pacific rapid tests market, by application
7.4.2.6.3. Rest of Asia-Pacific rapid tests market, by end user
7.4.3. Asia-Pacific rapid tests market, by product
7.4.4. Asia-Pacific rapid tests market, application
7.4.5. Asia-Pacific rapid tests market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil rapid tests market, by product
7.5.2.1.2. Brazil rapid tests market, by application
7.5.2.1.3. Brazil rapid tests market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia rapid tests market, by product
7.5.2.2.2. Saudi Arabia rapid tests market, by application
7.5.2.2.3. Saudi Arabia rapid tests market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa rapid tests market, by product
7.5.2.3.2. South Africa rapid tests market, by application
7.5.2.3.3. South Africa rapid tests market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA rapid tests market, by product
7.5.2.4.2. Rest of LAMEA rapid tests market, by application
7.5.2.4.3. Rest of LAMEA rapid tests market, by end user
7.5.3. LAMEA rapid tests market, by product
7.5.4. LAMEA rapid tests market, application
7.5.5. LAMEA rapid tests market, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Akers Biosciences, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Abbott Laboratories (Alere Inc.)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Becton, Dickinson and Company
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Bio-Rad Laboratories, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Danaher Corporation (Cepheid, Inc.)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Hologic, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Meridian Bioscience, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. OraSure Technologies, Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Quidel Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. F. Hoffmann-La Roche AG (Roche Diagnostics)
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
continue....
Check for discount@ https://www.kdmarketresearch.com/discount/3186
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us - KD Market Research
150 State Street, Albany,
New York, USA 12207
Email id sales@kdmarketresearch.com
No comments:
Post a Comment